Results 201 to 210 of about 7,123 (225)

[Pathogenesis and treatment of CIDP].

Rinsho shinkeigaku = Clinical neurology, 2006
CIDP is an autoimmune peripheral polyneuropathy. Clinical and electrophysiologic features indicate its heterogeneity, and such wide spectrum of the phenotype makes difficult to clarify complete pathogenesis. IVIg is an effective therapy no less than corticosteroids and plasmaphresis, and getting as the first choice for CIDP treatment due to the easy ...
openaire   +1 more source

Systematic literature review of burden of illness in chronic inflammatory demyelinating polyneuropathy (CIDP)

Journal of Neurology, 2020
Luis Querol, M Crabtree, E Priedane
exaly  

Multifocal enlargement and increased vascularization of peripheral nerves detected by sonography in CIDP: A pilot study

Clinical Neurophysiology, 2014
H Stephan Goedee, L H Visser
exaly  

CIDP

2013
openaire   +1 more source

CIDP in a HIV endemic population: A prospective case series from Johannesburg, South Africa

Journal of the Neurological Sciences, 2016
André Mochan, David G Anderson, Girish Modi   +2 more
exaly  

CIDP

2015
openaire   +1 more source

IVIG regulates BAFF expression in patients with chronic inflammatory demyelinating polyneuropathy (CIDP)

Journal of Neuroimmunology, 2014
Christian Ritter, Philipp Albrecht, Hans-Peter Hartung   +2 more
exaly  

CIDP-Therapie

DNP - Der Neurologe und Psychiater, 2012
openaire   +1 more source

Proinflammatory cytokines in serum and cerebrospinal fluid of CIDP patients

Neurological Research, 2012
Antonis Rombos, Vasiliki Zouvelou, Maria-Eleftheria Evangelopoulos   +2 more
exaly  

Immunoglobulin administration for the treatment of CIDP: IVIG or SCIG?

Journal of the Neurological Sciences, 2020
Jeffrey A Allen, M Chris Runken, Gil I Wolfe   +2 more
exaly